Business Wire

Panasonic to Team up with IBM Japan in Improving Semiconductor Manufacturing Processes

Share

On October 15, 2019, IBM Japan, Ltd. and Panasonic Corporation’s subsidiary, Panasonic Smart Factory Solutions Co., Ltd. (hereafter "Panasonic"), announced that the companies have agreed to collaborate to develop and market a new high-value-added system to optimize the overall equipment effectiveness (OEE) of customers’ semiconductor manufacturing processes and to realize high-quality manufacturing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191014005718/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Aims of the collaboration (Graphic: Business Wire)

As part of its circuit formation process business, Panasonic currently develops and markets edge devices and manufacturing methods that contribute to improving semiconductor manufacturing of advanced packaging. These new devices and methods include dry etching equipment, plasma dicers to produce high-quality wafers, plasma cleaners that increase metal and resin adhesion and high-accuracy bonding devices. This expertise will be combined with techniques and technology that IBM Japan has developed for semiconductor manufacturing to help Panasonic create smart factory technology. These include a data analysis systems including advanced process control (APC) and fault detection and classification (FDC), as well as an upper-layer manufacturing execution system (MES) — thus improving quality and automating production management in semiconductor manufacturing processes.

In recent years, IoT and 5G devices are becoming faster, smaller, and more multi-functional. This has given rise to manufacturing that is based on advanced packaging technology, in which a middle-end process (that combines the wafer process from the front-end process and the packaging technology from the back-end process) has been added between the front-end and back-end processes in semiconductor manufacturing.

Through the collaboration announced, IBM Japan and Panasonic will jointly develop a data analysis system that will be incorporated into Panasonic’s edge devices. The aim of this high-value-added system is to significantly reduce the number of engineering processes required, to stabilize product quality, and to improve the operating rates of manufacturing facilities. Specifically, the companies intend to develop an automatic recipe generation system for plasma dicers, which is a new advanced packaging production method that is drawing increased attention in the semiconductor manufacturing field, and a process control system that incorporates an FDC system in plasma cleaners — equipment that has demonstrated good results in the back-end process. Going forward, the new system and IBM Japan’s MES will be connected to optimize OEE factory-wide and to realize high-quality manufacturing.

The two companies intend to develop the new system for the back-end process first, then explore an expansion of the scope to the front-end process in the future.

Features of the new high-value-added system

1. Advancing plasma dicers through automatic recipe generation
The computing algorithm jointly developed by the two companies enables customers to enter their desired dicing shape (etching shape), which varies from product to product, and automatically generate equipment parameters consisting of several hundred combinations. This feature is expected to significantly reduce product launch times and engineering costs. It can also be applied to the APC system, which automatically adjusts equipment parameters according to varying processing quality from front- and back-end processes; which will keep processed shapes stable, resulting in a high-quality dicing process.

2. Advancing plasma cleaners through FDC
FDC continuously accumulates operational data from operating manufacturing equipment, detects failures through its own data analysis method, and enables the condition of equipment to be interpreted automatically. This feature generates equipment maintenance target areas and frequency needs, forecasts and prevents failures, optimizes maintenance scheduling, reduces equipment downtime, and improves operating rates.

IBM has been a leader in the IT industry for more than 100 years and a leader in the semiconductor field in R&D of advanced miniaturization processing technology — delivering solid business results at 300mm-semiconductor manufacturing plants across the world. Furthermore, as a solutions provider of production operation systems which enable non-stop full automation at factories, IBM has been contributing to the semiconductor manufacturing field for years. As semiconductors play a vital role in emerging technologies such as IoT and edge-computing, there are growing needs for greater sophistication and miniaturization of semiconductors. Working beyond conventional boundaries, IBM aims to promote the realization of smart factories through co-creation with Panasonic, thus providing new value to society.

Under its "Gemba Process Innovation" vision, Panasonic is expanding its B2B solutions business. The gemba, or physical site for frontline operations, refers to all places where products are made, moved or sold — the places where value is generated and problems must be confronted. By applying the company‘s 100-years of experience and expertise gained in the manufacturing industry with its sensing technologies and edge devices, Panasonic aims to co-create with its customers and partners to solve problems at the gemba. Panasonic is advancing the Gemba Process Innovation vision, aiming to become a total solutions integrator with offerings to the three main areas of manufacturing, logistics, and retail.

About IBM Japan
For more information on IBM Japan, visit https://www.ibm.com/ibm/jp/en/

About Panasonic
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, and B2B businesses. The company, which celebrated its 100th anniversary in 2018, has expanded globally and now operates 582 subsidiaries and 87 associated companies worldwide, recording consolidated net sales of 8.003 trillion yen for the year ended March 31, 2019. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: https://www.panasonic.com/global.

Source: https://news.panasonic.com/global/press/data/2019/10/en191015-2/en191015-2.html

Related Links
Smart Factory Solutions - Business Initiatives
https://www.panasonic.com/global/corporate/management/business-initiatives/factory.html

Factory Automation, Welding Machines - Panasonic Industrial Devices
https://industrial.panasonic.com/ww/products/fa-welding

Panasonic to Exhibit Digital Technology and Products for Smart Factory at CIIF 2019 (Sep 13, 2019)
https://news.panasonic.com/global/topics/2019/71801.html

Panasonic Signs Joint Business Development Agreement with Startup Linkwiz to Enhance Welding Processes in Manufacturing (Jun 17, 2019)
https://news.panasonic.com/global/press/data/2019/06/en190617-3/en190617-3.html

Panasonic Ramps Up Its Smart Factory Solutions Business in India (May 08, 2019)
https://news.panasonic.com/global/topics/2019/67894.html

EV GROUP AND PANASONIC TEAM UP ON RESIST PROCESSING SOLUTION FOR PLASMA DICING (Mar 13, 2019)
https://news.panasonic.com/global/press/data/2019/03/en190313-2/en190313-2.html

Panasonic to Open New B2B 'Customer Experience Center' in Tokyo in January (Dec 17, 2018)
https://news.panasonic.com/global/press/data/2018/12/en181217-2/en181217-2.html

[Video] Expediting Innovations and Co-creation - Panasonic Executive Interview
https://youtu.be/BM9FYnPh-lY

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

IBM Japan
External Relations, TEL: +81-3-3808-5120

Panasonic
Global Communications Department, TEL: +81-3-3574-5664

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

HiddenA line styled icon from Orion Icon Library.Eye